Sunho Biologics, Inc. (HKG:2898)

Sunho Biologics Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-82.09	-79.97	-132.7	-51.99	-70.63
Depreciation & Amortization	9.66	9.43	8.64	8.81	6.07
Loss (Gain) From Sale of Investments	-	-	-	-0.06	-0.15
Stock-Based Compensation	28.35	28.35	30.08	2.04	8.3
Other Operating Activities	41.19	-44.79	46.86	5.03	4.17
Change in Inventory	-0.16	-0.16	0.06	0.29	0.49
Change in Accounts Payable	-14.46	-14.46	9.33	-1.45	1.3
Change in Other Net Operating Assets	-7.43	-7.43	-2.92	2.74	-2.21
Operating Cash Flow	-24.94	-109.02	-40.65	-34.59	-52.65
Capital Expenditures	-41.05	-39.37	-1.03	-1.44	-5.52
Sale (Purchase) of Intangibles	-9.89	-9.89	-	-	-5
Investment in Securities	-227.84	-294.17	-85.6	0.06	0.15
Other Investing Activities	-35.02	-1.6	2.74	0.02	0.01
Investing Cash Flow	-314.51	-345.04	-83.89	-1.36	-10.36
Short-Term Debt Issued	-	47.28	23	42.7	74.24
Total Debt Issued	66.1	47.28	23	42.7	74.24
Short-Term Debt Repaid	-	-32.51	-34.52	-15.14	-9.26
Long-Term Debt Repaid	-	-2.4	-0.02	-	-
Total Debt Repaid	-47.33	-34.91	-34.54	-15.14	-9.26
Net Debt Issued (Repaid)	18.77	12.37	-11.54	27.56	64.98
Issuance of Common Stock	-	419.78	270.52	-	-
Other Financing Activities	-2.18	-25.61	-3.48	-0.46	-
Financing Cash Flow	16.59	406.53	255.5	27.1	64.98
Foreign Exchange Rate Adjustments	0.15	1.44	-7.7	-	-
Net Cash Flow	-322.72	-46.08	123.25	-8.84	1.97
Free Cash Flow	-65.98	-148.39	-41.68	-36.03	-58.17
Free Cash Flow Margin	-388135.29%	-390505.26%	-237.73%	-1947.30%	-1808.71%
Free Cash Flow Per Share	-0.44	-1.16	-0.45	-0.40	-0.64
Cash Interest Paid	1.48	0.7	-	-	-
Levered Free Cash Flow	-118.56	-471.93	315.72	-26.49	-
Unlevered Free Cash Flow	-117.83	-471.35	316.15	-23.32	-
Change in Working Capital	-22.04	-22.04	6.47	1.59	-0.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.